Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis

被引:42
作者
Ferrari, Silvano [1 ]
Bianchi, Bernardo [1 ]
Savi, Andrea [1 ]
Poli, Tito [1 ]
Multinu, Alessandra [1 ]
Balestreri, Ayredo [1 ]
Ferri, Andrea [1 ]
机构
[1] Univ Parma, Div Head & Neck, Dept Maxillofacial Surg, I-43100 Parma, Italy
关键词
D O I
10.1016/j.joms.2007.06.631
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: Bisphosphonates are a class of drugs with several uses. Primarily, they are used to treat bone metastases, multiple myeloma, Paget's disease, and osteoporosis. However, the use of bisphosphonates can lead to osteonecrosis of the jaws. Here, we present our experience treating this widely discussed disease. Patient and Methods: We describe a patient who underwent surgical reconstruction of the mandible with a fibula free flap after total mandibulectomy, performed to treat osteonecrosis induced by the use of intravenous bisphosphonates complicated by a mandibular fracture. Endosseous implants were inserted simultaneously to optimize the length and outcome of surgery. Results: Osteonecrosis of the jaws is a treatment challenge, and several approaches have been suggested. in this patient, the use of a fibula free flap to reconstruct the mandible was a winning strategy. The patient is now free from disease, and the esthetic results were optimal. Conclusions: With the simultaneous placement of endosseous dental implants, the functional outcome was optimal, with no significant complications or recurrence. (c) 2008 American Association of Oral and Maxillofacial Surgeons.
引用
收藏
页码:999 / 1003
页数:5
相关论文
共 16 条
[1]  
Abu-Id MH, 2006, ORAL MAXILLOFAC SURG, V10, P73, DOI 10.1007/s10006-005-0670-0
[2]  
ADRAC, 2005, AUST ADV DRUG REACT, V24, P3
[3]   Aetiology of bone disease and the role of bisphosphonates in multiple myeloma [J].
Ashcroft, AJ ;
Davies, FE ;
Morgan, GJ .
LANCET ONCOLOGY, 2003, 4 (05) :284-292
[4]   New foundations in understanding osteonecrosis of the jaws [J].
Assael, LA .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (02) :125-126
[5]   Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[6]  
CARTER GD, 2004, AUSTR PRESCRIBER, V27, P32
[7]  
DJULBEGOVIC B, 2002, COCHRANE DB SYST REV, V3
[8]   Intravenous bispbosphonates and osteonecrosis [J].
Greenberg, MS .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2004, 98 (03) :259-260
[9]   Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure-activity relationships in J774 macrophages [J].
Luckman, SP ;
Coxon, FP ;
Ebetino, FH ;
Russell, RGG ;
Rogers, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (11) :1668-1678
[10]   Severe osteomyelitis of the jaw in longterm survivors of multiple myeloma: A new clinical entity [J].
Lugassy, G ;
Shaham, R ;
Nemets, A ;
Ben-Dor, D ;
Nahlieli, O .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (06) :440-441